top
Search terms
Results 1 - 10 of 1272 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 128
Escardio

Wessel BROUWER (Amsterdam, NL) 14:00 P1690 Cardiac microvascular dysfunction in anderson-fabry disease: a dipyridamole PET-based study in a cohort of male and female patients Franco CECCHI (Florence, ...

Poster session 2: Hereditary cardiomyopathies

Date : 28/08/2011 Item size : 180000 bytes
Escardio

14:00 P3448 Characteristics and outcome of hypertrophic cardiomyopathy in Noonan, Costello, and cardio-facio-cutaneous syndromes Damien BONNET (Paris, FR) 14:00 P3449 Ethnic differences in the ...

Poster session 4: Hypertrophic cardiomyopathy

Date : 29/08/2011 Item size : 182610 bytes
Escardio

14:00 P6144 Clinical characteristics and cardiac magnetic resonance for the patients received repeat percutaneous transluminal septal myocardial ablation in refractory hypertrophic obstructive ...

Poster session 7: Cardiomyopathies I

Date : 02/09/2014 Item size : 130412 bytes
Escardio

Ivan ZEMSKOV (St. Petersburg, RU) 14:00 P6160 More impaired diastolic function of light chain amyloidosis contribute to poor prognosis compared with transthyretin amyloidosis: result from ...

Poster session 7: Cardiomyopathies II

Date : 02/09/2014 Item size : 129432 bytes
Ehjournal

Introduction Despite the same electrophysiological abnormality, the risk of stroke and systemic embolism in atrial fibrillation (AF) ranges from <1%/year to >20%/year and can be assessed by simple ...

European Heart Journal, CURRENT OPINION, Raffaele De Caterina, A. John Camm

Date : 14/12/2014 Item size : 431415 bytes
Ehjcardiovascrec

Abstract Objective: Most cardiac myosin binding protein C (cMyBP-C) gene mutations causing familial hypertrophic cardiomyopathy (FHC) result in C-terminal truncated proteins. By using an ...

Cardiovascular Research, Original Article, Antonio Sarikas, Lucie Carrier, Carolus Schenke, Daniela Doll, Jeanne Flavigny, Katrin S. Lindenberg, Thomas Eschenhagen, Oliver Zolk

Date : 01/04/2005 Item size : 297398 bytes
Ehjcardiovascrec

Abstract Objective: Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is the predominant PPAR subtype in cardiac cells and plays a prominent role in the regulation of cardiac lipid ...

Cardiovascular Research, Research Article, Anna Planavila, Ricardo Rodríguez-Calvo, Mireia Jové, Liliane Michalik, Walter Wahli, Juan C. Laguna, Manuel Vázquez-Carrera

Date : 01/03/2005 Item size : 291556 bytes
Ehjcardiovascrec

To this end, the molecular biology of calcineurin and its direct downstream transcriptional effector NFAT are discussed in the context of the genetic studies that established the existence of this ...

Cardiovascular Research, Review, Orlando F Bueno, Eva van Rooij, Jeffery D Molkentin, Pieter A Doevendans, Leon J De Windt

Date : 01/03/2002 Item size : 584271 bytes
Epeuropace

Heart Rhythm UK position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes Abstract Whilst the decision ...

Europace, POSITION PAPER, Clifford J. Garratt, Perry Elliott, Elijah Behr, A. John Camm, Campbell Cowan, Stephanie Cruickshank, Andrew Grace, Michael J. Griffith, Anne Jolly, Pier Lambiase, Pascal ...

Date : 01/08/2010 Item size : 607247 bytes
Ehjcardioimaging

Introduction Hypertrophic cardiomyopathy (HCM) is a primary heart disease characterized by great diversity of morphological, functional, and clinical features.13 The 12-lead electrocardiography (ECG) ...

Eur Heart J Cardiovasc Imaging, ORIGINAL PAPERS, Hala Mahfouz Badran, Mohamed Fahmy Elnoamany, Ghada Soltan, Mohamed Ezat, Mohamed Elsedi, Raed Ahmed Abdelfatah, Magdi Yacoub

Date : 01/05/2012 Item size : 328691 bytes